Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CLB
CLB logo

CLB Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
16.100
Open
16.180
VWAP
16.03
Vol
11.79K
Mkt Cap
760.38M
Low
15.990
Amount
188.87K
EV/EBITDA(TTM)
11.38
Total Shares
46.56M
EV
847.79M
EV/OCF(TTM)
22.80
P/S(TTM)
1.46
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.
Show More

Events Timeline

(ET)
2026-02-04
17:20:00
Sees Q1 Revenue of $124M-$130M
select
2026-02-04
17:20:00
Core Lab Reports Q4 Revenue of $138.3M
select
2025-10-22 (ET)
2025-10-22
17:03:14
Core Laboratories Announces Q3 Earnings Per Share of 30 Cents, Exceeding Estimates of 19 Cents
select
2025-09-30 (ET)
2025-09-30
16:18:17
Core Laboratories purchases geological services firm Solintec
select
2025-07-23 (ET)
2025-07-23
17:19:07
Core Laboratories sees Q3 EPS 18c-22c vs. 25c last year
select
2025-07-23
17:17:43
Core Laboratories reports Q2 EPS ex-items 19c vs. 22c last year
select

News

seekingalpha
8.0
02-05seekingalpha
Core Laboratories Declares Quarterly Dividend of $0.01
  • Quarterly Dividend Declaration: Core Laboratories has declared a quarterly dividend of $0.01 per share, maintaining consistency with previous dividends, which reflects the company's stability in the current economic environment.
  • Dividend Yield: The forward yield of this dividend stands at 0.2%, indicating the company's ongoing commitment to shareholder returns while also suggesting a healthy cash flow situation.
  • Payment Schedule: The dividend will be payable on March 9, with a record date of February 16 and an ex-dividend date of February 13, providing investors with a clear timeline that aids in their investment decisions.
  • Historical Performance Context: Core Laboratories' dividend policy aligns with its historical earnings data, demonstrating the company's continued efforts in providing technology to replace tier-1 oil inventory, thereby enhancing its competitive position in the industry.
seekingalpha
9.5
02-04seekingalpha
Core Laboratories Q4 Earnings Exceed Expectations
  • Earnings Beat: Core Laboratories reported a Q4 non-GAAP EPS of $0.21, surpassing expectations by $0.02, indicating robust profitability and boosting investor confidence in the company's financial health.
  • Significant Revenue Growth: The company achieved Q4 revenue of $138.3 million, a 7.0% year-over-year increase, exceeding analyst expectations by $7.9 million, showcasing Core Laboratories' strong performance amid recovering market demand and solidifying its market position.
  • Technology Replacement Potential: Core Laboratories is focused on providing technology to replace tier-1 oil inventory, and as the global energy transition accelerates, the adoption of this technology is expected to create new growth opportunities and enhance its competitive edge in the industry.
  • Positive Future Outlook: The earnings beat not only reflects current market performance but also lays a foundation for sustained growth, attracting increased investor interest as demand for efficient energy solutions rises.
seekingalpha
9.5
02-03seekingalpha
Core Laboratories to Announce Q4 Earnings on February 4
  • Earnings Announcement Schedule: Core Laboratories is set to release its Q4 2023 earnings report on February 4 after market close, with consensus EPS estimates at $0.19, reflecting a 13.6% year-over-year decline, while revenue is expected to reach $130.4 million, a 0.9% year-over-year increase.
  • Historical Performance Review: Over the past two years, Core Laboratories has exceeded EPS estimates 63% of the time and revenue estimates 50% of the time, indicating a degree of stability in its earnings performance amidst market fluctuations.
  • Expectation Revision Dynamics: In the last three months, EPS estimates have seen one upward revision with no downward adjustments, while revenue estimates have experienced one upward and one downward revision, suggesting mixed market sentiment regarding the company's future performance.
  • Market Focus: Core Laboratories provides technology aimed at replacing Tier-1 oil inventory, and the market's attention on its earnings report extends beyond the numbers to how the company navigates industry challenges and its potential for future growth.
Globenewswire
7.5
01-16Globenewswire
Christina Lake Cannabis Sells 99 Acres of Non-Core Land for $551,000
  • Asset Disposition: Christina Lake Cannabis has completed the sale of 99 acres of non-core land in British Columbia for gross proceeds of $551,000, which will enhance the company's liquidity and improve its balance sheet.
  • Strategic Focus: The land sale follows a reassessment of assets post-Midway acquisition, ensuring the company remains focused on its core operating assets to support long-term growth objectives.
  • Use of Proceeds: Proceeds from the sale will be allocated to general working capital, further enhancing financial flexibility and supporting future business expansion.
  • Market Positioning: As a licensed cannabis producer with over 950,000 square feet of outdoor grow space, Christina Lake Cannabis aims to maintain its competitive edge through this asset optimization in a highly competitive market.
PRnewswire
9.5
01-05PRnewswire
Core Laboratories Schedules Q4 2025 Earnings Call for February 5, 2026
  • Earnings Call Schedule: Core Laboratories will host its Q4 2025 earnings call on February 5, 2026, at 7:30 a.m. CST, where executives will discuss financial and operational results, ensuring timely access to critical information for investors.
  • Earnings Release Preview: The company will issue its earnings press release after market close on February 4, 2026, which can be accessed through the company’s website, enhancing transparency and boosting market confidence.
  • Webcast Registration: Investors are required to log on to the website at least 15 minutes prior to the call to register for the listen-only webcast, ensuring efficient information dissemination.
  • Replay and Transcript Availability: For those unable to attend the live session, a replay and transcript will be available shortly after the call on the company’s website, further improving accessibility of information and communication with investors.
NASDAQ.COM
9.5
2025-07-28NASDAQ.COM
Core Labs Posts Flat Revenue in Q2
  • Q2 2025 Financial Performance: Core Laboratories reported Q2 2025 revenue of $130.2 million, slightly exceeding expectations but flat year-over-year, with adjusted EPS at $0.19, reflecting a 13.6% decline from the previous year. The company emphasized operational progress in international markets and maintained a focus on technological innovation and cost management.

  • Future Outlook and Risks: For Q3 2025, Core Laboratories forecasts revenue between $127.5 million and $134.5 million, with potential risks stemming from oil and gas industry cycles, U.S. market unpredictability, and tariffs affecting production materials. The company plans to maintain its dividend at $0.01 per share while prioritizing free cash generation and reinvestment in technology.

Wall Street analysts forecast CLB stock price to rise
1 Analyst Rating
Wall Street analysts forecast CLB stock price to rise
0 Buy
0 Hold
1 Sell
Moderate Sell
Current: 0.000
sliders
Low
11.50
Averages
11.50
High
11.50
Current: 0.000
sliders
Low
11.50
Averages
11.50
High
11.50
Stifel
Hold
downgrade
$13 -> $12
AI Analysis
2025-07-16
Reason
Stifel
Price Target
$13 -> $12
AI Analysis
2025-07-16
downgrade
Hold
Reason
Stifel lowered the firm's price target on Core Laboratories to $12 from $13 and keeps a Hold rating on the shares. Oil service stocks have underperformed the S&P 500 in 2025, and catalysts have been largely negative, the analyst tells investors in a research note. Entering Q2 earnings season, the firm believes shares will be range bound until estimates stop falling.
Citi
Neutral
downgrade
$16 -> $13
2025-05-13
Reason
Citi
Price Target
$16 -> $13
2025-05-13
downgrade
Neutral
Reason
Citi lowered the firm's price target on Core Laboratories to $13 from $16 and keeps a Neutral rating on the shares. The firm updated models for a collection of Smid-cap oil and gas equipment and services stocks to incorporate updated rig count forecasts and recent earnings.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CLB
Unlock Now

Valuation Metrics

The current forward P/E ratio for Core Laboratories Inc (CLB.N) is 22.91, compared to its 5-year average forward P/E of 25.51. For a more detailed relative valuation and DCF analysis to assess Core Laboratories Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
25.51
Current PE
22.91
Overvalued PE
35.10
Undervalued PE
15.93

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
15.26
Current EV/EBITDA
12.26
Overvalued EV/EBITDA
19.90
Undervalued EV/EBITDA
10.63

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.90
Current PS
1.52
Overvalued PS
2.54
Undervalued PS
1.27

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

so what Company is best for me
Intellectia · 79 candidates
Price: $5.00 - $400.00Relative Vol: >= 3List Exchange: XNYS, XNAS, XASEOne Week Rise Prob: >= 65One Week Predict Return: >= 5.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ITGR logo
ITGR
Integer Holdings Corp
3.00B
VERX logo
VERX
Vertex Inc
2.12B
SCHW logo
SCHW
Charles Schwab Corp
164.81B
SPHR logo
SPHR
Sphere Entertainment Co
3.95B
IRON logo
IRON
Disc Medicine Inc
2.42B
CRI logo
CRI
Carter's Inc
1.55B
Show stocks with the a b c d pattern
Intellectia · 40 candidates
Market Cap: <= 2.00BPrice: <= $20.00Relative Vol: >= 1.50Support Resistance Relationship: PriceAroundResistanceShares Outstanding: <= 50,000,000
Ticker
Name
Market Cap$
top bottom
CLB logo
CLB
Core Laboratories Inc
909.38M
ANSC logo
ANSC
Agriculture & Natural Solutions Acquisition Corp
465.74M
VHI logo
VHI
Valhi Inc
409.25M
NPAC logo
NPAC
New Providence Acquisition Corp III
395.43M
CCIX logo
CCIX
Churchill Capital Corp IX
391.19M
GPAT logo
GPAT
GP-Act III Acquisition Corp
385.25M

Whales Holding CLB

D
Disciplined Growth Investors, Inc.
Holding
CLB
+4.98%
3M Return
A
Ariel Investments, LLC
Holding
CLB
-0.24%
3M Return
T
Tontine Management, LLC
Holding
CLB
-1.76%
3M Return
C
CWA Asset Management Group, LLC
Holding
CLB
-1.80%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Core Laboratories Inc (CLB) stock price today?

The current price of CLB is 15.99 USD — it has decreased -2.08

What is Core Laboratories Inc (CLB)'s business?

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.

What is the price predicton of CLB Stock?

Wall Street analysts forecast CLB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLB is11.50 USD with a low forecast of 11.50 USD and a high forecast of 11.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Core Laboratories Inc (CLB)'s revenue for the last quarter?

Core Laboratories Inc revenue for the last quarter amounts to 138.25M USD, increased 6.98

What is Core Laboratories Inc (CLB)'s earnings per share (EPS) for the last quarter?

Core Laboratories Inc. EPS for the last quarter amounts to 0.15 USD, decreased -6.25

How many employees does Core Laboratories Inc (CLB). have?

Core Laboratories Inc (CLB) has 3500 emplpoyees as of March 11 2026.

What is Core Laboratories Inc (CLB) market cap?

Today CLB has the market capitalization of 760.38M USD.